Cargando…
In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma
There are currently no effective treatments for advanced‐stage papillary renal cell carcinoma (PRCC). The goal of this study is to define potential DNA methylation‐based markers and treatment targets for advanced‐stage type 2 PRCC. Progressive DNA methylation changes and copy number variation (CNV)...
Autores principales: | Yang, Man, Hlady, Ryan A., Zhou, Dan, Ho, Thai H., Robertson, Keith D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745825/ https://www.ncbi.nlm.nih.gov/pubmed/31361072 http://dx.doi.org/10.1002/cam4.2402 |
Ejemplares similares
-
Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2012) -
PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study
por: Lai, Hung-Cheng, et al.
Publicado: (2014) -
DNA methylome analysis identifies BMI‐related epigenetic changes associated with non‐small cell lung cancer susceptibility
por: Li, Guyanan, et al.
Publicado: (2021) -
Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases
por: Yang, Jing, et al.
Publicado: (2016) -
A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer
por: Lin, Alexander J., et al.
Publicado: (2018)